bioMérieux S.A.

Paris Stock Exchange BIM.PA

bioMérieux S.A. Operating Income Margin for the year ending December 31, 2023: 11.95%

bioMérieux S.A. Operating Income Margin is 11.95% for the year ending December 31, 2023, a -23.39% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • bioMérieux S.A. Operating Income Margin for the year ending December 31, 2022 was 15.60%, a -31.43% change year over year.
  • bioMérieux S.A. Operating Income Margin for the year ending December 31, 2021 was 22.75%, a 28.68% change year over year.
  • bioMérieux S.A. Operating Income Margin for the year ending December 31, 2020 was 17.68%, a 42.89% change year over year.
  • bioMérieux S.A. Operating Income Margin for the year ending December 31, 2019 was 12.37%, a -17.60% change year over year.
Key data
Date Operating Income Margin EBT Margin Net Income Margin EBITDA Margin
Market news
Loading...
SV Wall Street
Paris Stock Exchange: BIM.PA

bioMérieux S.A.

CEO Mr. Pierre Boulud
IPO Date July 7, 2004
Location France
Headquarters 376 Chemin De l'Orme
Employees 13,409
Sector Healthcare
Industries
Description

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Similar companies

EDEN.PA

Edenred SA

USD 33.69

0.11%

DIM.PA

Sartorius Stedim Biotech S.A.

USD 221.40

-1.05%

ERF.PA

Eurofins Scientific SE

USD 53.09

-0.83%

IPN.PA

Ipsen S.A.

USD 126.17

0.49%

TEP.PA

Teleperformance SE

USD 96.37

1.85%

StockViz Staff

February 7, 2025

Any question? Send us an email